Celsius Holdings (NASDAQ:CELH) 주식

CELSIUS HOLDINGS INC

Celsius Holdings

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and soon-to-be-acquired Alani Nu energy drinks and snacks portfolio. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

Pattaya,,Thailand,-,Circa,April,,2023:,Entrance,To,Calvin,Klein

Mid Cap

News

Movers

Trading Ideas

CELH

COOP

CORT

LOAR

PRGS

VRRM

지난주 상위 중형주를 추적하는 S&amp;P400 지수는 9.1% 하락했고, 특히 금요일에만 4.8% 급락했다. 그러나 이러한 매도세 속에도 시장 흐름을 역행하며 상승한 중형주는 다음과 같다.

굿이어·램웨스턴 등 지난주 S&amp;P 400 급락에도 상승한 중형주 9종목 (3월 31일~4월 4일)

Lucid EV. Photo by Around the World Photos on Shutterstock

Equities

Tech

ARQT

CPRX

DGNX

GLNG

LCID

SBSW

STNE

지난 일주일 동안 가장 실적이 좋았던 중형주 10개 종목은 다음과 같다. 디지넥스, 넥스트데케이드, 셀시우스, 시그넷 주얼러스, 뉴 포트리스, 밀로즈, 아커티스, 루시드, 캐털리스트, 스톤코

셀시우스·루시드·시그넷 등 지난주 급등한 중형주 10종목 (3월 17일~21일)

Pony.ai,Signpost,At,Autonomous,Driving,Startup,Headquarters,In,Silicon,Valley

$SEI

APLD

NVDA

PONY

VICR

VNET

지난주 가장 성과가 좋았던 중형주 9개 종목은 다음과 같다. 포니AI, 셀시우스, 위라이드, 어플라이드 디지털, 솔라리스, 바이코, GDS, 브이넷, 굿이어타이어

포니AI, 셀시우스, 위라이드 등 지난주 급등한 중형주 9종목 (2월 17일~21일)

Celsius Holdings Inc

JPMorgan analyst Andrea Teixeira reiterated the Overweight rating on Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) on Wednesday, <a href="https://www.benzinga.com/quote/CELH/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price forecast of $44.</a>
On Tuesday, the firm reported first-quarter adjusted earnings per share of 18 cents. It missed the analyst<a href="https://www.benzinga.com/news/earnings/25/05/45223081/celsius-stock-fizzles-after-q1-miss-revenue-slide" target="_blank" rel="noreferrer noopener"> consensus estimate of 19 cents</a>.
Quarterly sales of $329.28 million (down 7% year over year) missed the Street view of $344.03 million.
Teixeira pointed out several positive aspects, including improving retailer scanner data for Celsius—suggesting underlying strength beyond the headline last three weeks data—and accelerating momentum for Alani Nu.
Management's tone during the earnings call appeared cautious rather than overly optimistic since gross margin came in better than expected. 
Also Read: <a target="_blank" href="https://www.benzinga.com/content/44646402/celsius-heats-up-acquisition-analyst-upgrade-fuel-momentum" rel="noreferrer noopener">Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum</a>
Given that investor positioning was likely skewed toward short interest ahead of the report, Teixeira writes that the post-earnings stock rebound may be partially driven by short covering after the market had time to digest the results.
The analyst maintains a &#8216;bullish&#8217; view on Celsius. The company boasts a favorable growth-at-a-reasonable-price (GARP) profile within the energy drinks category.
Teixeira also argues that energy drinks regained momentum, in contrast to most consumer packaged goods sectors. Consumption trends have generally weakened, making Celsius relatively more attractive in the current market environment.
Celsius also benefits from several consumer &#8220;megatrends&#8221; (i.e., health-conscious consumers demanding clean energy alternatives).
These broader trends are expected to support sustained growth and give Celsius a competitive edge. Teixeira writes that they enable the brand to capture additional market share both in the U.S. and international markets.
Price Action: CELH shares are trading lower by 0.20% to $35.45 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45256510/exclusive-trumps-approval-rating-drops-in-reader-survey-after-100-days-could-stock-market-be-to-blame" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Trump&#8217;s Approval Rating Drops In Reader Survey After 100 Days, Could Stock Market Be To Blame?</a></li>
</ul>
Image: Shutterstock

Markets

Analyst Ratings

General

Celsius Stock Slips After Q1 Miss, But Analyst Sees Strong Long-Term Growth Drivers

Financial giants have made a conspicuous bearish move on Celsius Holdings. Our analysis of options history for Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) revealed 9 unusual trades.
Delving into the details, we found 22% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $279,007, and 3 were calls, valued at $89,197.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $27.5 to $40.0 for Celsius Holdings over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Celsius Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Celsius Holdings's substantial trades, within a strike price spectrum from $27.5 to $40.0 over the preceding 30 days.
<h3>Celsius Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746626499_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.8</td>
<td>$2.57</td>
<td>$2.8</td>
<td>$35.00</td>
<td>$92.3K</td>
<td>4.9K</td>
<td align="right">330</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.99</td>
<td>$2.8</td>
<td>$2.82</td>
<td>$35.00</td>
<td>$64.4K</td>
<td>4.9K</td>
<td align="right">330</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$8.25</td>
<td>$8.0</td>
<td>$8.2</td>
<td>$40.00</td>
<td>$39.3K</td>
<td>139</td>
<td align="right">0</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/09/25</td>
<td>$2.85</td>
<td>$2.58</td>
<td>$2.7</td>
<td>$32.50</td>
<td>$33.7K</td>
<td>1.0K</td>
<td align="right">325</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$5.6</td>
<td>$5.45</td>
<td>$5.45</td>
<td>$32.50</td>
<td>$30.5K</td>
<td>35</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Celsius Holdings</h3>
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and soon-to-be-acquired Alani Nu energy drinks and snacks portfolio. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
Following our analysis of the options activities associated with Celsius Holdings, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Celsius Holdings</h3>
<ul>
<li>Currently trading with a volume of 629,560, the CELH's price is down by -1.18%, now at $35.1. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 90 days.</li>
</ul>
<h3>Expert Opinions on Celsius Holdings</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $45.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $45. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Celsius Holdings, which currently sits at a price target of $44. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Celsius Holdings with a target price of $44. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Celsius Holdings, which currently sits at a price target of $48. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Celsius Holdings with a target price of $45. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Celsius Holdings with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Spotlight on Celsius Holdings: Analyzing the Surge in Options Activity

Needham analyst Gerald Pascarelli reiterates Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and maintains $45 price target.

Price Target

Reiteration

Needham Reiterates Buy on Celsius Holdings, Maintains $45 Price Target

Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) shares are trading lower on Tuesday after the company released its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45215666/celsius-holdings-reports-first-quarter-2025-financial-results" rel="noreferrer noopener">first-quarter results</a>.
The beverage giant reported adjusted earnings per share of 18 cents, missing the analyst <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus estimate of 19 cents</a>. Quarterly sales of $329.28 million (down 7% year over year) missed the street view of $344.03 million.
CELSIUS brand&nbsp;retail sales declined 3% year over year with a dollar share of 10.9%, down 140 basis points from the prior year.&nbsp;
Celsius highlighted that the revenue was affected by the timing and structure of our U.S. distributor incentive program and elevated retail promotional allowances, which were more heavily weighted toward the latter part of the quarter compared to the same period in 2024.&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44977669" rel="noreferrer noopener">PepsiCo CEO Warns Of Tariffs Led &#8216;Increase In Supply Chain Costs,&#8217; Cuts Annual Profit Outlook</a>
&#8220;While revenue was down year over year, retail scanner data showed a 2% increase in dollar sales for the 13 weeks ended Mar. 30, 2025, compared to the prior 13-week period,&#8221; the company said in a press release.
The company&#8217;s adjusted EBITDA slumped 21% year over year to $69.7 million, while quarterly net income fell 43% to $44.4 million.
Celsius closed the acquisition of Alani Nu on Apr. 1, 2025. Alani Nu surpassed $1 billion in trailing 52-week retail sales for the period ended Apr. 13.
The company exited the quarter with cash and equivalents worth $977.285 million. Inventories-net totaled $141.159 million.
Gross margin in the quarter under review expanded by 110 basis points to 52.3%. The increase in gross margin is attributed to sourcing efficiencies for raw and package materials.
On a pro forma basis, Celsius said it captured 16.2% of U.S. energy drink category dollar share in the first quarter.
Price Action: CELH shares are trading lower by 3.57% to $32.68 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/05/45215281/trump-orders-fda-to-fast-track-us-drug-production-as-tariff-threat-looms-on-imported-medicines-cites-national-security-concerns" target="_blank" rel="noreferrer noopener">Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns</a></li>
</ul>
Photo by MDV Edwards via Shutterstock

Earnings

Celsius Stock Fizzles After Q1 Miss, Revenue Slide

Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $0.19 by 5.26 percent. This is a 33.33 percent decrease over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $329.28 million which missed the analyst consensus estimate of $344.03 million by 4.29 percent. This is a 7.43 percent decrease over sales of $355.71 million the same period last year.

Earnings Misses

Celsius Holdings Q1 Adj. EPS $0.18 Misses $0.19 Estimate, Sales $329.28M Miss $344.03M Estimate

ACLS

AHCO

ALAB

ALGS

ALGT

AMTM

ANDE

ANET

ANGI

ARDT

ARIS

ARMK

ARRY

ATKR

ATOM

ATRO

AUDC

AVNS

AVNT

AVNW

AZEK

BALL

BBNX

BCAB

BLDP

BRLT

BWIN

BWMN

CCCS

CCLD

CDRE

CGAU

CGBD

CHMI

CHRD

CIFR

CIGI

CLDT

CLOV

COTY

CPAY

CPIX

CPNG

CRCT

CRIS

CRMD

CRSR

CRUS

CURI

CVGI

CXDO

CYTK

DASH

DAWN

DDOG

DOCN

DRCT

DRVN

DVAX

ENLT

EOSE

Embraer-Empresa Brasileira De Aeronautica

ESPR

EVGO

Earnings Scheduled For May 6, 2025

Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Celsius Holdings to report an earnings per share (EPS) of $0.21.
The announcement from Celsius Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.04, leading to a 27.77% increase in the share price the following trading session.
Here's a look at Celsius Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.10</td>
<td>0.03</td>
<td>0.24</td>
<td>0.19</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.14</td>
<td>0</td>
<td>0.28</td>
<td>0.27</td>
</tr>
<tr>
<td>Price Change %</td>
<td>28.000000000000004%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746457389_0.png" alt="eps graph" />
<h3>Market Performance of Celsius Holdings's Stock</h3>
Shares of Celsius Holdings were trading at $34.46 as of May 02. Over the last 52-week period, shares are down 55.58%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Insights Shared by Analysts on Celsius Holdings</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Celsius Holdings.
Analysts have provided Celsius Holdings with 9 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $44.78, suggesting a potential 29.95% upside.
<h3>Comparing Ratings with Competitors</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Primo Brands and National Beverage, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Primo Brands, with an average 1-year price target of $42.75, suggesting a potential 24.06% upside.</li>
<li>Analysts currently favor an Sell trajectory for National Beverage, with an average 1-year price target of $41.0, suggesting a potential 18.98% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Primo Brands and National Beverage, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Celsius Holdings</td>
<td>Buy</td>
<td>-4.39%</td>
<td>$166.67M</td>
<td>-5.72%</td>
</tr>
<tr>
<td>Primo Brands</td>
<td>Buy</td>
<td>28.66%</td>
<td>$430.10M</td>
<td>-9.85%</td>
</tr>
<tr>
<td>National Beverage</td>
<td>Sell</td>
<td>-1.12%</td>
<td>$98.95M</td>
<td>10.43%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Celsius Holdings ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity.
<h3>All You Need to Know About Celsius Holdings</h3>
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and soon-to-be-acquired Alani Nu energy drinks and snacks portfolio. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
<h3>Key Indicators: Celsius Holdings's Financial Health</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Celsius Holdings's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -4.39%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Celsius Holdings's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -7.09%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -5.72%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Celsius Holdings's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.36%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Celsius Holdings's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.05.
<a href="https://www.benzinga.com/quote/CELH/earnings">To track all earnings releases for Celsius Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Celsius Holdings's Earnings Preview

JP Morgan analyst Andrea Teixeira maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Overweight and raises the price target from $39 to $44.

JP Morgan Maintains Overweight on Celsius Holdings, Raises Price Target to $44

Celsius Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) is scheduled to report its first-quarter results on Tuesday, May 6, <a href="https://www.benzinga.com/insights/short-sellers/25/04/44634247/how-is-the-market-feeling-about-celsius-holdings">before market open</a>.
According to JPMorgan, material negative earnings revisions seem to be in the company&#8217;s rearview.
The Celsius Holdings Thesis: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e5520feece4e60001201237/andrea-teixeira">Analyst Andrea Teixeira</a> maintained an Overweight rating, while raising the price target from $39 to $44.
The Celsius Holdings Thesis: The company is likely to report sales and earnings at $338 million and 19 cents per share, short of consensus of $343 million and 20 cents per share, Teixeira said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Celsius Holdings' sales trends are recovering, "inflecting back to positive growth in some recent periods," she added.
The company is witnessing energy category acceleration, while most staples categories are seeing softening consumption trends, the analyst stated.
The acquisition of Alani Nu, which closed on April 1, 2025, is expected to become accretive from the second quarter, Teixeira said. "With that, our 2025E revenue/EPS/EBITDA move to $2.2B (+64% YOY), $0.95 (+37.7% YOY), and $453M (+77.2% YOY) and our 2026E revenue/EPS/EBITDA move to $2.8B (+27.7% YOY), $1.29 (+35.7% YOY), and $600M (+32.5% YOY)," she further wrote.
CELH Price Action: Shares of Celsius Holdings had risen by 1.72% to $35.47 at the time of publication on Friday.
Read More: 
<ul>
<li><a href="https://in.benzinga.com/content/44890152/j-b-hunt-transport-overcorrects-into-a-buying-opportunity">Short Sellers Gave Up on These 3 Names Recently</a></li>
</ul>
Image: Shutterstock

Analyst Color

Previews

Celsius Holdings Q1 Preview: Inflecting To Growth, Negative Earnings Revisions Unlikely, Says Analyst

WIIM

BRBR

CART

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

CHEF

COKE

FIZZ

FRPT

HNST

LFVN

LOCL

MGRX

PFGC

SISI

SMPL

USFD

Shares of companies within the broader consumer staples sector are trading lower amid overall market weakness.

UBS analyst Peter Grom maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and raises the price target from $43 to $48.

UBS Maintains Buy on Celsius Holdings, Raises Price Target to $48

Piper Sandler analyst Michael Lavery maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Overweight and raises the price target from $43 to $44.

Piper Sandler Maintains Overweight on Celsius Holdings, Raises Price Target to $44

ABEV

BRFS

CENT

CENTA

COCO

COST

Fomento Economico Mexicano S.A.B. De C.V.

HFFG

IPAR

ISPR

MDLZ

MGPI

MNST

PSMT

SNYR

TBBB

UNFI

UPXI

USNA

WALD

WEST

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Needham analyst Gerald Pascarelli maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and raises the price target from $40 to $45.

Needham Maintains Buy on Celsius Holdings, Raises Price Target to $45

The S&amp;P400 index, which tracks the top mid-cap stocks, fell 9.1% last week and 4.8% last Friday. However, these mid-cap stocks emerged as winners. Are they in your portfolio?
<ol>
<li>Corcept Therapeutics Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) shares surged 36.28% after the company disclosed that the ROSELLA Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer met its primary endpoint of improved progression-free survival, as assessed by blinded <a href="https://www.benzinga.com//node/44569564" target="_blank" rel="noreferrer noopener">independent central review (PFS-BICR)</a>.</li>
<li>Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) stock escalated 28.44% after the company announced Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) will acquire it in <a href="https://www.benzinga.com//node/44565671" target="_blank" rel="noreferrer noopener">a $9.4 billion all-stock deal</a>.</li>
<li>Verra Mobility Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRRM#NASDAQ">VRRM</a>) shares rose 10.90%.</li>
<li>Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) stock rose 10.35% after Deutsche Bank upgraded it from Hold to Buy <a href="https://www.benzinga.com/quote/gt/analyst-ratings" target="_blank" rel="noreferrer noopener">and announced a $13 price forecast</a>.</li>
<li>Progress Software Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) stock upped 9.30% after the company reported better-than-expected <a href="https://www.benzinga.com//node/44570749" target="_blank" rel="noreferrer noopener">first-quarter financial results</a>.</li>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) stock rose 9.24% after the company reported better-than-expected third-quarter financial results and issued <a href="https://www.benzinga.com//node/44629158" target="_blank" rel="noreferrer noopener">FY25 sales guidance above estimates</a>.</li>
<li>Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) stock rose 5.62%.</li>
<li>Loar Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOAR#NYSE">LOAR</a>) shares increased 5.26% after the <a href="https://www.benzinga.com//node/44560215" target="_blank" rel="noreferrer noopener">company reported quarterly results</a>.</li>
<li>PVH Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) shares gained 4.68% last week following strong <a href="https://www.benzinga.com//node/44572437" target="_blank" rel="noreferrer noopener">Q4 financial results</a> and the announcement of plans to enter into a $500 million accelerated share repurchase program.</li>
</ol>
Photo by Sorbis via Shutterstock

How Some Mid Cap Stocks Outshone The S&P 400's Dramatic Drop Last Week (Mar 31-Apr 4)

Celsius Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NYSE">CELH</a>) short percent of float has fallen 15.55% since its last report. The company recently reported that it has 28.39 million shares sold short, which is 15.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Celsius Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743706822_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celsius Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celsius Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Celsius Holdings's peer group average for short interest as a percentage of float is 5.06%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Celsius Holdings?

Shares of companies within the broader consumer staples sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Risk sentiment remains under pressure at the start of the week on Wall Street, with tech-heavy indexes sliding while commodities advance, as traders fear a new wave of price pressures following <a href="https://www.benzinga.com/topic/tariffs">the upcoming tariffs announcement.</a>
The S&amp;P 500 experienced a turbulent morning session, first hitting its lowest level in over six months before clawing back some ground and trimming losses. Nevertheless, the benchmark equity index is on track for its worst month since September 2022, having fallen 7% in March.
Tech stocks remained the weakest link, with the Nasdaq 100 down 1.1% as semiconductor names weighed on the broader sector. The iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) dropped 1.9% and is down 11.9% month-to-date — also marking its worst month since September 2022.
President Donald Trump's threats toward Iran over the weekend pushed crude oil prices up by 3.5% for the session, marking the biggest single-day gain since October.
Energy-related stocks outperformed and are on pace to log their fourth consecutive positive month, now up 8.5% year-to-date.
Meanwhile, gold prices continued to smash record highs, with bullion surging over 1% to $3,115 per ounce. Quarterly gains have reached 18% — the strongest three-month rally since 2009.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) inched up 1.2% to $83,400, fighting to avoid a second consecutive monthly decline.
<h1 class="wp-block-heading">Monday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,688.45</td>
<td>0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,555.01</td>
<td>-0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,001.35</td>
<td>-1.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,075.33</td>
<td>-1.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.4% to $553.82.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) inched 0.2% up to $416.59.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 1.1% to $463.82.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) tumbled 0.9% to $198.50.</li>
<li>The&nbsp;Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.5%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) saw the worst performance, down 1.2%.</li>
</ul>
<h1 class="wp-block-heading">Monday&#8217;s Stock Movers</h1>
<ul>
<li>Celsius Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) surged more than 7% after Truist upgraded the stock from Hold to Buy and lifted its price target from $35 to $45.</li>
<li>Wolfspeed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) roared 11% following a 52% drop on Friday. </li>
<li>Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares plunged nearly 10% after the resignation of Dr. Peter Marks, the FDA's top vaccine official, sparked concerns over potential delays in the review of new treatments.</li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/etfs/25/03/44564323/tech-linked-etfs-suffer-outflows-in-march-as-ai-mini-bubble-pops-on-tariff-panic">Tech-Linked ETFs Suffer Outflows In March As AI &#8216;Mini Bubble&#8217; Pops On Tariff Panic</a></li>
</ul>
Photo: Shutterstock Professional via Shutterstock

Sector ETFs

Broad U.S. Equity ETFs

Commodities

Econ #s

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

MRNA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

WOLF

Stocks Fall, S&P 500 Eyes Worst Month In Almost Two Years, Oil Rallies: What's Driving Markets Monday?

U.S. stocks were mixed, with the Nasdaq Composite falling over 1% on Monday.
Shares of Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) rose sharply during Monday's session after the company announced it will be acquired by Rocket Companies in a $9.4 billion <a href="https://www.benzinga.com/quote/COOP">all-stock deal</a>.
Mr. Cooper Group shares jumped 16.3% to $ 121.54 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Corcept Therapeutics Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) shares jumped 84.7% to $100.95 after the company announced it met its primary endpoint for its Phase 3 ROSELLA trial of Relacorilant.</li>
<li>United Microelectronics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) shares rose 12.6% to $7.38.</li>
<li>Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) gained 12.6% to $28.20.</li>
<li>Southern States Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSBK#NASDAQ">SSBK</a>) rose 10.2% to $35.79 after FB Financial announced it will acquire the company in a $381 million merger deal.</li>
<li>B&amp;G Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>) jumped 9.6% to $7.05.</li>
<li>Park Ha Biological Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHH#NASDAQ">PHH</a>) gained 9.5% to $14.00.</li>
<li>Cryoport, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) gained 8.8% to $6.63 after DHL Group announced it will acquire its CRYOPDP business for $138 million.</li>
<li>Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) rose 8.2% to $36.42.</li>
<li>Nexxen International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) gained 7.6% to $8.20.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) rose 6.8% to $1.9550.</li>
<li>Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) shares gained 5.4% to $167.34. Discover Financial Services will report its first quarter 2025 results after the market closes on Wednesday, April 23.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) gained 4% to $9.14. Deutsche Bank analyst Edison Yu upgraded Goodyear Tire &amp; Rubber from Hold to Buy and announced a $13 price target.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44554966/pvh-progress-software-and-3-stocks-to-watch-heading-into-monday">PVH, Progress Software And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>
Photo: Shutterstock

Intraday Update

Mr. Cooper Group, Southern States Bancshares, Corcept Therapeutics And Other Big Stocks Moving Higher On Monday

Comments

Celsius Holdings

뉴스

파트너 / 기고자

벤징가 글로벌